new studies on glp 1 The risk in patients taking GLP-1 drugs for obesity or diabetes is higher than with other diabetes drugs, suggest GLP-1 Agonists Weight Loss Drugs

Different medications produce different degrees of gastric emptying delay, and individual responses vary significantly

When stressed, the body produces cortisol which, if chronically elevated, can promote weight gain (especially around the belly) and also stimulate appetite for high-calorie comfort foods

Exendin-9 administered IP was unable to block this effect, indicating a dominant role for CNS GLP-1R populations (77)

Adherence to medication regimens is significantly improved when administration times align with established daily habits

The potential role of GLP1-RAs in rheumatologic diseases (including arthritis, gout, osteoarthritis, and osteoporosis) as well as autoimmune skin diseases (such as psoriasis and hidradenitis suppurativa) sharing common pathophysiological pathways with PsD